PRICE T ROWE ASSOCIATES INC /MD/ - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$54,037
-23.4%
1,991,002
-13.2%
0.01%
-20.0%
Q2 2023$70,532
-20.9%
2,294,416
-7.3%
0.01%
-23.1%
Q1 2023$89,210
-9.9%
2,475,947
-1.1%
0.01%
-18.8%
Q4 2022$98,979
-99.9%
2,504,532
+6.9%
0.02%
+6.7%
Q3 2022$94,135,000
-4.8%
2,342,810
-0.4%
0.02%
+25.0%
Q2 2022$98,901,000
+12.3%
2,352,542
+4.0%
0.01%
+33.3%
Q1 2022$88,096,000
-2.9%
2,261,199
-0.7%
0.01%
+12.5%
Q4 2021$90,761,000
+14.3%
2,277,559
+3.7%
0.01%
+14.3%
Q3 2021$79,390,000
-12.0%
2,196,736
-0.1%
0.01%
-12.5%
Q2 2021$90,172,000
-12.2%
2,199,853
-6.6%
0.01%
-20.0%
Q1 2021$102,691,000
-36.1%
2,354,218
-26.6%
0.01%
-37.5%
Q4 2020$160,618,000
-53.6%
3,209,155
-61.0%
0.02%
-60.0%
Q3 2020$346,280,000
-11.1%
8,231,050
+2.6%
0.04%
-18.4%
Q2 2020$389,491,0008,022,4710.05%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders